<DOC>
	<DOC>NCT01179412</DOC>
	<brief_summary>The purpose of this study is to determine the outcomes of treating epidemic keratoconjunctivitis with 2% povidone-iodine.</brief_summary>
	<brief_title>Treatment of Epidemic Keratoconjunctivitis With 2% Povidone-iodine</brief_title>
	<detailed_description>The study design was a prospective interventional case series. Our institutional ethical committee approved the study protocol in April 2004. We performed this study between July 2004 and December 2009. During this period, there were 2 episodes of EKC epidemic. The first episode was in 2006 and the second in 2009.</detailed_description>
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Keratoconjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis, Viral</mesh_term>
	<mesh_term>Povidone-Iodine</mesh_term>
	<mesh_term>Iodine</mesh_term>
	<mesh_term>Cadexomer iodine</mesh_term>
	<mesh_term>Povidone</mesh_term>
	<criteria>patients who were diagnosed with EKC at the outpatient ophthalmic unit children younger than six years women being pregnant or during lactation history of allergy to povidoneiodine prior ocular surgery contact lens usage and chronic eye diseases with current eye medications.</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2010</verification_date>
</DOC>